Entries Tagged 'IPO Reviews' ↓

Maytas Infra IPO : Apply in Maytas Infra for Listing gains

Maytas Infra IPO which is oversubscribed by around 6 times till today will close for subscription tomorrow. According to the Maytas Infra subscription details as of today most of the subscription has come from institutional investors. Maytas Infra IPO subscription tomorrow will be over done as the investors sentiment in realty stocks is high and the markets breadth is extremely positive.

Apply in Maytas Infra IPO for  excellent listing gains keeping in mind that the Maytas Infra IPO will be heavily oversubsribed apply for the higher end if you have cash in hand. Allotment in Maytas Infra IPO will be very hard to get as this is a small issue hence apply for the maximum amount available with you for good allotment in Maytas Infra IPO.

Investors who will recieve the allotment will get good gains on listing of Maytas Infra IPO as even the grey market price is also high.

Keep checking this blog regularly for more updates on the Indian IPOs Allotment and Listing Dates.

Saamya Biotech IPO Review : Analysts opinions mixed

Saamya Biotech IPO which is open for subscription with 15 lakh shares of Rs 10 each to raise around Rs 15 crore. Subscription of Saamya Biotech IPO will close on September 28, 2007.

Majority of experts said to apply for the IPO as they believe that Saamya Biotech has been issued at a reasonable price and the profile of the company is clean considering its directors. People should subscribe with long term view in this IPO.

Experts said that Finchimica, Spa Italy has 100% buying agreement with Saamya Biotech for anti-cancer drug which would be a fetching point for this company on the long term.

Some Analysts have expressed their opinion in not to invest in this IPO as the financial performance of this company is not great and in the post paid capital of the company the promoters stake would be only 7%.

Considering the size of the issue and financing pattern of the project investment is not advised in this IPO.

Based on the above opinions you can give a miss to this IPO, if you are an agressive investor you can invest keeping in view the current market conditions where what ever IPO comes for listing is giving bumper gains.

If you need more information regarding the Saamya Biotech IPO click here.

Supreme Infra IPO : Apply for long term gains

Mumbai based Supreme Infrastructure India limited (SIIL),a medium sized construction company, is open for subscription with an initial public offering (IPO) of 34.75 lakh equity shares at a price band of Rs 95-108 per share with 100% book building process.

The company is going to raise at around Rs 33.01 crore from the lower end and 37.53 crore from upper price band of the issue. Supreme Infra IPO will close for subscription on September 26, 2007.

Supreme Infrastructure is an excellent bet, to invest at the upper price band and the Counter demand in this IPO is very good. Looking at the present market conditions and how subsribers have shown interest in Consolidated Construction IPO, investors cannot miss to apply in the issue as Supreme Infrastructure IPO listing will be excellent and even the grey market price suggests good returns to the investors.

If you have excess funds with you dont go for the minimum lot which is 60 shares but apply for the maximum quantity to increase the chances of getting allotment in the Supreme Infra IPO.

Apply in Consolidated Construction Consortium IPO (CCCL IPO) for listing gains

Consolidated Construction Consortium Ltd CCCL IPO likely to end up with good subsription tommorrow. The recent cut in the fed rate had a very good impact on the Indian Stock Markets, the Indian Markets reacted very positively and the Realty sector stocks have outperformed all the other stocks in the last 3 sessions.

The CCCL IPO seems to have lot of faith from the investors and has gained impressive subscription numbers, by today the Consolidated Construction IPO has been subscribed by 8.37 times.

Institutional Investors category in the Consolidated Construction IPO has been subscribed by about 14 times. By the current trend it is likely that the CCCL IPO is sure to give good listing gains.

Mostly the CCCL IPO would be subscribed heavily and investors would surely get high returns on listing, so we recommend
Investors to apply for this issue.

Apply in Koutons Retail IPO for Listing Gains

Koutons Retail IPO which was subsribed by 1.96 times by today will get heavily subsribed by the end of subscription date which is on 21st september. Most of the Analysts have suggested to apply for the Koutons Retail IPO as the market trend is very good and considering the previous interest shown by the investors in Vishal Retail .

Koutons Retail IPO will generate excellent gains on listing as the IPO will be heavily oversubsribed by around 40-50 times. Though Koutons Retail IPO listing gains would be high, Allotment would be low.

Investors with surplus cash could consider investing in the Koutons Retail IPO and others could wait till the end of the final day for Koutons Retail IPO subscription details and then decide to whether apply in this IPO or leave it.

For all other Indian IPOs currently open check Issues Open Now  and if you like to check the upcoming IPOs in BSE and NSE click here.

CCCL IPO Review : Consolidated Construction IPO apply for listing gains

Consolidated Construction Consortium (CCCL) IPO is open for subscription to the public from today with 37,00,000 equity shares at a price band between Rs 460 and Rs 510 per equity share and the issue will close for subscription on September 21, 2007.

Accrording to the experts opinion on CCCL IPO majority of them have suggested that investors can apply for the issue and investors will recieve listing gains. Most of them said CCCL is a good issue and the demand in this counter is very good.

The company will be raised Rs 170.20 crore at lower end of price band and Rs 188.70 crore at higher end.

The equity shares are proposed to be listed on the National Stock Exchange of India and the Bombay Stock Exchange. The issue would constitute 10.01% of the post-issue paid up capital of the company. This issue has been assigned IPO grade 3 by ICRA.

The objects of the issue are to finance the acquisition of construction infrastructure, investment in subsidiaries, expenditures towards skill and management development centre, repayment of loans and expenditure for general corporate purposes.

The total value of its order book as on July 31, 2007, is Rs 20,495.68 million. These projects include industrial structures, IT parks, commercial building, airport terminal buildings, hotel, hospitals and educational institutions

The book running lead managers to the issue are Enam Securities Private Limited and Kotak Mahindra Capital Company Limited while the co-book running lead manager is Spark Capital Advisors (India) Private Limited. Karvy Computershare Pvt Ltd is the registrar to the issue.

Kaveri Seed Company IPO looks attractive

Kaveri Seed Company Limited (KSCL), the Secunderabad based maker of agriculture inputs, is entering the capital markets via the initial public offer (IPO) route to mobilise funds upto Rs 680 million with 40 Lakh shares.The IPO will open on September 6 2007 and closes on September 11 2007

Company Profile:

Kaveri Seed Company which was incorporated in year 1986  is engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc. Recently the company forayed into micro-nutrients and bio-products,production of non-hybrid seeds. The production, processing and R&D facilities of the company are located in Andhra Pradesh and Karnataka.

Objectives of the issue:

Kaveri Seeds intends to used the IPO funds in setting up of marketing offices and godowns, corn cob drying plants, biotechnology lab and seed processing plant. In addition,the company plans to acquire farmland for R&D facilities, upgradation of existing seed processing plants and meeting the working capital requirements. The benefits of these plans are expected to contribute to the financials of the company from November 2008 onwards.

Financials:

KSCL delivered first-rate financial performance during fiscal 2007. The company registered substantial growth of 3.63 times in earnings during fiscal 2007 compared with the previous fiscal. It recorded earnings of Rs 105.40 million during fiscal 2007, as against Rs 29.02 million in fiscal 2006. The substantial rise in earnings was a result of the improved operating margins and higher realisation on hybrids of cotton, bajra and paddy. Earnings per share during fiscal 2007 jumped 81.76% to Rs 15.05 from Rs 8.28 in the fiscal year 2006.

KSCL reported a rise of 35.22% in total income to Rs 672.38 million during fiscal 2007, compared with previous fiscal. The operating margins during fiscal 2007 improved to 26.02% compared with 8.25% in fiscal 2006. In spite of healthy revenue growth, KSCL observed a decline in material cost which helped the company to report outstanding numbers.

Valuation:

At the issue price band, the shares of KSCL are available at price to earnings (P/E) multiple of 9.96x at the floor price and 11.30x at the cap price. The shares of its peers, Monsanto India and Bayer Crop Science are available at P/E multiple of about 17.87x and 21.67x respectively. On the other hand, the shares are available at price to book value (P/BV) multiple of 5.54x at the floor price to 6.27x at the cap price.

Based on the above stated valuations,Kaveri Seed Company IPO looks attractive and one can expect a good listing gains subject to the market conditions.